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Abstract
The Centers for Medicare and Medicaid are requiring long-term care facilities (LTCFs) to
implement antibiotic stewardship programs (ASPs) to alleviate overuse of antibiotics in the
nursing home population. Current research shows that the benefits of ASPs include improved
patient outcomes, reduced adverse events related to Clostridium difficile (C-diff) infection,
improvement in rates of antibiotic susceptibilities, and optimized resource utilization. This
project addressed the problem of antibiotic overuse and misuse in the geriatric population and
whether the implementation of an ASP reduced the overuse of antibiotics, C-diff infection, and
resistance rates in the LTCF. Application of the Johns Hopkins nursing model and Centers for
Disease Control framework informed this project. An ASP was implemented by the organization.
This project evaluated the program preASP and postASP over a 10-month period. A descriptive
analysis was used to compare the number of new antibiotic starts, C-diff cases, and resistant
cases before and after ASP implementation. The total number of cases of resistance declined
from 12 to 10 cases after the ASP was implemented, which was a 16.67% decline. The number
of monthly new antibiotic orders for the time period evaluated declined from 120 to 110
respectively, which was an 8.3% change. There was no change in the number of C-diff
infections. The results demonstrated that implementing the ASP led to a decline in antibiotic
misuse, overuse, and resistance cases. This project supports social change by expanding the
healthcare team’s knowledge regarding the project problem and informing future interventions to
be implemented to help reduce antibiotic overuse and misuse in the geriatric population.
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Section 1: Nature of the Project
Introduction
Antibiotic overuse and over ordering is a problem nationwide. Antibiotics are to be used
to fight infections caused by bacteria (U.S. Food and Drug Administration, 2017). Slowing down
the use of antibiotics and assessing the need for them will help retain the efficacy of the
antibiotics (Sprenger, 2015). Antibiotic sstewardship programs (ASPs) have been proven to
reduce antibiotic overuse, over ordering, and the adverse effects of resistance and Clostridium
difficile (C-diff) (Sprenger, 2015). In a study conducted in 610 general practices in the United
Kingdom, researchers found that prescribing fewer antibiotics for colds, ear infections, and
coughs helped to prevent resistance (Guilford et al., 2016). The Centers for Disease Control
(CDC) stated that any action taken regarding improving antibiotic use is expected to have a
positive impact on the residents, resistance, and the adverse effect of C-diff (U.S. Department of
Health, 2015). Improving the quality of care provided and safety for one’s patients is the
rationale for implementing ASPs. The implementation of an ASP at a long-term care facility
(LTCF) impacts social change within the elderly population by affecting the residents, hopefully,
with positive outcomes of lowered C-diff infections and resistant cases. The awareness of
antibiotic usage will increase nursing knowledge, potentially leading to social change. This
project supports Walden University’s mission to promote positive social change. The question I
sought to answer with this project is: In the geriatric population, does the implementation of an
ASP reduce the overuse of antibiotics, C-diff, and resistance rates in the LTCF compared with no
ASP?
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Problem Statement
The Centers for Medicare and Medicaid (CMS) is requiring LTCFs to implement ASPs
(Mongan, 2015, para. 1). These stewardship programs are to alleviate overuse of antibiotics in
the nursing home population (citation). Current research shows that the benefits include
improved patient outcomes, reduced adverse events related to C-diff infection, and improvement
in rates of antibiotic susceptibilities to targeted antibiotics with optimized resource utilization
across the continuum of care (Barlem et al., 2016). Antibiotic overuse is of great concern in
LTCFs and, in response to this concern, the CDC and the CMS have mandated that LTCFs
implement ASPs to help eliminate the overuse of antibiotics in the elderly population (citation).
Antibiotic use in LTCFs is an issue that needs to be addressed nationwide to slow the emergence
of antibiotic-resistant bacteria (Dall, 2016).
According to Johns Hopkins (Ahern Gould, 2017), antibiotic resistance is an issue that
must be addressed by healthcare providers and patients. The increasing cost of antibiotics, the
rate of new antibiotics being introduced, and the resistance issues being seen makes it difficult
for the health care provider to choose the optimal antibiotic today (citation). It has been through
history that if health care professionals are not careful, antibiotics will lose their efficacy (Ahern
Gould, 2017). On a local level, the city of Houston, Texas has established its own Antimicrobial
Stewardship Committee, comprised of clinical experts, to address the antibiotic resistance
problem in the Houston area with the goal to work with other community members in the area to
preserve antibiotics (Offiong, 2017). In addition, the CDC has provided the city of Houston with
a grant to host an annual symposium to combat this practice problem of antibiotic resistance
(Offiong, 2017).
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Purpose Statement
According to the CDC (2017) antibiotic stewardship requires national attention. The
CDC has identified antibiotic misuse and overuse as a gap in practice and has developed multiple
goals to address this issue. The goals include establishing national guidelines on antibiotic use
and cutting inappropriate prescribing (citation). In addition, the CDC includes the initiative that
CMS (2015) adopted for implementation of ASPs, which is mandated in LTCFs (U.S.
Department of Health, 2017). The practice question is: In the geriatric population does the
implementation of an ASP reduce the overuse of antibiotics and affect C-diff rates in the LTCF
compared with no ASP? Doctor of Nursing Practice (DNP) scholarly projects are those that are
focused on changing outcomes using evidence-based practice (Terry, 2015). In this doctoral
project, the problem was antibiotic overuse, and the intervention to address the problem was a
newly implemented ASP at the practicum site. The scholarly project focused on whether
antibiotic overuse declined with the implementation of the ASP and whether the development of
the adverse outcome of C-diff and resistance was affected by the implementation of an ASP.
This scholarly project evaluated a current healthcare practice or program, the ASP. Antibiotic
overuse is of great concern in LTCFs and in response to this concern the CDC and the CMS have
mandated that LTCFs implement ASPs to help eliminate the overuse of antibiotics in the elderly
population (citation). Antibiotic use in LTCFs is an issue that needs to be addressed nationwide
to slow emergence of antibiotic-resistant bacteria (Dall, 2016).
Nature of the Doctoral Project
In this doctoral project, I evaluated the problem of antibiotic overuse and the effects of a
newly implemented ASP at the practicum site. The project focused on whether antibiotic overuse
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declines with the implementation of the ASP and whether the development of the adverse
outcome of C-diff and resistance is affected by the implementation of an ASP within this LTCF.
The sources of evidence that were collected for this project included the number of new
antibiotic starts and the number of C-diff and resistant infections comparing pre-ASP to postASP implementation. The nurses documented monthly on antibiotic tracking logs all new
antibiotic starts, cases of resistance, and positive cultures for C-diff. The facility staff collected
and de-identified the data for the project and provided it to me. The approach used to organize
and analyze the evidence was the CDC and Institute for Healthcare Improvement (IHI) for
effective implementation of an ASP change driver framework (U.S. Department of Health,
2017). It was anticipated that the prevalence of new antibiotics ordered, the number of resistant
cases, and C-diff infections would decrease post-ASP implementation.
Significance
The stakeholders at the LTCF for the ASP included the director of regulatory compliance,
quality assurance nurse, medical director, laboratory consultant, pharmacist consultant, director
of nurses (DON), assistant director of nurses (ADON), nursing staff, physicians, and family
members. Table 1 describes the roles, responsibilities, and tasks for each stakeholder for this
project. Each stakeholder had an important part in the successful implementation and
maintenance of the ASP. The stakeholders had a vested interest in reducing antibiotic use and the
adverse effect of resistance and C-diff which will benefit the residents and the LTCF.
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Table 1
Stakeholder roles, responsibilities, and tasks
Director of Nurses
(DON)

Director of
Regulatory
Compliance
Medical Director
Quality Assurance
(QA) Nurse

Co-champion and infection control lead. Co-develop agendas.
Lead / Supervise trainings.
Ensure Monitoring of the new interventions.
Help develop staff training.
Review whether materials are used.
Develop findings with PIP related to monitoring the new
intervention.
Champion

Champion
Monitoring Staff: Collect/Analyze/Aggregate Data to evaluate
program effectiveness and sustainability

Assistant Director
of Nurses (ADON)

Stewardship Staff: Assist with program education to nurses and
implementation of program

Minimum Data Set
(MDS) Nurse

Stewardship Staff: Assist with program education to nurses and
implementation of program

Consulting
Pharmacist

Co-champion

Laboratory
Consultant

Co-champion

Antibiotic Stewardship trainee or infectious disease
knowledgeable
Assist with antibiogram annually and provide culture reports and
summaries for the LTCF

The end users, which are those individuals who will be implementing/using the ASP,
included the lab personnel, pharmacy personnel, physicians, nurse practitioners, nurses,
administrator, and the QA registered nurse (RN). Engaging the stakeholders and end users was
an important step in the success of sustaining the ASP. Ensuring that one considers the opinions,
key information, and input of the stakeholders helps to establish the plan with everyone’s input
(Young, 2012). Lowering antibiotic overuse and over ordering was the desired outcome of this
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project. Slowing down the use of antibiotics and assessing the need for them will help retain the
efficacy of the antibiotics (Sprenger, 2015).
Block (2016) shared that ASPs have been proven to reduce antibiotic overuse, over
ordering, and the adverse effects of resistance and C-diff. If antibiotic prescriptions are
appropriate and careful consideration is employed when ordering antibiotics, resistance will
decline, which will improve patient safety from adverse effects and improve the quality of care
provided (Lee, Cho, & Lee, 2013). A desired result of implementing an ASP at this LTCF was to
improve the quality of patient care in that there will be a sustained reduction in inappropriate
antibiotic therapy being prescribed and a reduction in adverse effects from antibiotic overuse and
over ordering. Antimicrobial stewardship is an important step in reducing resistance (Zukowski,
2016). This doctoral project could potentially be modified to be used in clinics, doctor offices,
and home health agencies. Increasing nurses’ awareness of antibiotic usage, this practice
problem, and implementing antibiotic stewardship programs will increase nursing knowledge,
potentially effecting social change in this practice area by reducing overuse and misuse of
antibiotics.
Dall (2016) shared that between 40% and 70% of antibiotics prescribed are inappropriate
to residents in LTCFs. Over 23,000 people die each year due to the adverse effect of antibiotic
resistance and more than 2 million people become infected with resistant bacteria (citation). If
nothing is done this can become over 10 million lives by 2050 (Nevada Public Health, 2017).
Summary
Antibiotic overuse and over ordering is a practice problem that must be addressed at this
LTCF and worldwide. This is an issue that cannot be ignored, and the World Health
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Organization (WHO) is requesting that all countries develop an antimicrobial action plan (WHO,
2016). The city of Houston has developed an antimicrobial stewardship committee and is
working to reduce antibiotic overuse and over ordering (Offiong, 2017). CMS has mandated that
LTCFs implement an ASP to assist in combating this problem (U.S. Department of Health,
2015). This doctoral project evaluated the effectiveness of implementing an ASP relating to
antibiotic overuse and C-diff infection rates. The CDC/IHI framework was used to measure the
effectiveness of the ASP program preimplementation versus postimplementation over a 10month period. The facility staff documented, tracked, and collected data on logs capturing all
new antibiotic starts, resistant cases, and C-diff infections before and after implementation of the
ASP. It was anticipated that the implementation of the ASP would result in a decrease in
antibiotic starts, cases of resistance, and in C-diff rates. The model, relevance to nursing practice,
local background and context, role of the DNP student, role of the project team and will be
discussed in the next section of this report.
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Section 2: Background and Context
Introduction
Antibiotic overuse and misuse is a problem in LTCFs (Lockhart, 2017). Lockhart (2017)
posited that overusing antibiotics leads to resistance and when one needs antibiotics they may not
be effective. The purpose of this project was to evaluate the effectiveness of an ASP in the LTCF
setting related to overuse, resistance, and clostridium difficile infections. The question I sought
to answer in this project was: In the geriatric population, does the implementation of an ASP
reduce the overuse of antibiotics, C-diff, and resistance rates in the LTCF compared with no
ASP? ASPs are necessary to reduce the misuse and over ordering of antibiotics and the adverse
effects of resistance and C-diff (Tiberg, Torney, & Vanderhorst, 2017). ASPs are required in the
LTCF to provide a higher level of safety for all residents. Residents in high-use nursing homes
are at risk even if they did not take antibiotics themselves (Daneman et al., 2015). When
planning translational activities and goals for projects, it is important to include the mission and
operational practices of the organization (White, Dudley-Brown, & Terharr, 2016).
I chose the Johns Hopkins model for the project, along with the CDC and IHI change
driver framework for ASPs. In this section, I will discuss the concepts, models, and theories,
relevance to nursing practice, local relevance of the problem, role of the DNP student in relation
to the doctoral project, and role of the project team.
Concepts, Models, and Theories
The Johns Hopkins model was chosen as the project model for this ASP quality
improvement project due to its viability and because it was the best fit. The Johns Hopkins
model has three main components: practice question, evidence, and translation (Johns Hopkins
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Medicine, 2017). The practice question is as follows: “In the geriatric population does the
implementation of an ASP reduce the overuse of antibiotics and affect C-diff rates in the LTCF
compared with no antibiotic stewardship program?”. According to the LTCF practicum site
mission, vision, goals, and operational practices, their professional staff is "committed to serving
the needs of the independent retirement, assisted living, and healthcare residents with respect,
kindness, and hospitality" (citation, p.1). The mission statement further presented this LTCF as a
place for everyone, regardless of how much help they need (citation). The fact that this LTCF
community was described as being filled with loving people who are ready to welcome their
patients (C. Klappenbach, personal communication, November 8, 2017) was part of the planning
for this project. Application of the Johns Hopkins nursing model to the ASP project in the LTCF
included development of the practice question, evidence searches, critique of the evidence,
summary of the evidence, and evaluating the strength of the evidence (see White, 2016). The
second phase (evidence) included searches regarding ASP development, implementation, and
evaluation in the past 5 years that are authoritative (citation). The third phase included evaluation
of the ASP at the LTCF. The final phase, per White (2016), included implementing, evaluating,
developing tools, and communicating findings. The practicum site has implemented the ASP,
collected the data, and communicated the findings through the ongoing quarterly quality
assurance meetings. As a DNP student, I analyzed and evaluated the data related to the outcomes
for antibiotic use, C-diff infection, and resistance rates before and after ASP implementation.
The framework chosen for this project was the antibiotic sstewardship measured framework
established by the CDC in collaboration with the IHI for effective implementation of an ASP in
the LTCF environment (U.S. Department of Health, 2017).
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This model has been explained by Schaffer et al. (2013) as a nursing practice model that
identifies the EBP question using a team approach, includes research and critique, and develops
recommendations based upon the strength of the evidence. The model also helps determine the
feasibility while creating an action plan, implementing change, evaluating, and communicating
findings (Schaffer et al., 2013). Newhouse (2007) defined the Johns Hopkins evidence-based
practice model as a model of evidence, whereby such evidence assists in making decisions about
nursing practice, education, and research. The quality of the research, its relevance to the clinical
setting, and whether the benefit of it is greater than any negative effects were considerations
when choosing a model to affect nursing practice (Newhouse, 2007).
The framework (CDC/IHI Antibiotic Stewardship Drivers and Change Package) included
the conceptual model with the key drivers for implementing and providing a change package for
decreasing antibiotic misuse and assisting facilities to have positive resident outcomes (U.S.
Department of Health 2017a). The intent of the change package was to establish a
multidisciplinary team that works collaboratively to implement the interventions over time to
positively impact and reduce inappropriate antibiotic use (U.S. Department of Health, 2017). The
CDC/IHI antibiotic stewardship framework provided several options for selected measures to
evaluate outcomes of an ASP (see Table 2).
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Table 2
Antibiotic Stewardship Measurement framework
Outcomes

Measure

Healthcare-associated C. difficile
infections

Rate of healthcare-associated C. difficile per
10,000 pt. days
When C. diff is a “rare event”: days (or
admissions) between C. diff associated disease

Pharmacy cost for antibiotics

Total pharmacy cost for antibiotics per month
When census is variable: Pharmacy cost for
antibiotics per discharge per month

Antibiotic-related adverse drug
events (ADEs)

Currently not feasible with this method to
evaluate this outcome in the time frame for
evaluation

Antibiotic resistant healthcare
associated pathogens

Percent of antibiotic resistant healthcareassociated pathogens i.e. prevalence. Note:
targeting pathogens based on local
circumstances, i.e., MRSA, VRE, etc.

(CDC, October 26, 2017).
The measures selected for this project included prevalence rate of C-diff and resistance per 300
patient days (10 months), or days between C-diff associated disease if found rare at the facility,
and the number of new antibiotic starts comparing pre-ASP implementation with post-ASP
implementation over a 10-month period from July 11, 2017 (ASP implementation date) to May
15, 2018. Rare is defined for the scope and timeframe proposed for this project as less than two
positive resident resistant lab results per 300 resident days. I chose an evaluation period of 300
patient days because 10,000 days have not occurred since the regulations were first required and
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implemented in July 2017. The pharmacy cost measure was not chosen by me due to a lack of
available data and a change in the pharmacy company providing services to the LTCF in the
fourth quarter of 2017 at the practicum site.
Relevance to nursing practice
CMS requires LTCFs to implement ASPs to alleviate overuse of antibiotics in this setting
(Mongan, 2015, para. 1). According to Dall (2016), 40-70% of antibiotics prescribed are
inappropriate to residents in LTCFs. Research has shown that the benefits of implementing an
ASP include improved patient outcomes, reduced adverse events related to C-diff infection, and
improved rates of antibiotic susceptibilities to targeted antibiotics with optimized resource
utilization across the continuum of care (Barlem et al., 2016). Antibiotic overuse in LTCFs is a
problem and in response, the government passed legislation mandating that LTCFs implement
ASPs in 2017 to help eliminate the overuse of antibiotics in the elderly population. Lockhart
(2017) noted that antibiotic resistance can lead to death. Add summary to fully conclude the
paragraph.
The cost of antibiotics is increasing; the rate of new antibiotics being introduced and the
resistance issues being seen makes it difficult for the health care provider to choose the optimal
antibiotic today (Hopkins, 2017). Hopkins (2017) reported that is antibiotics are not prescribed
and used carefully, the drugs can lose their efficacy. The CDC newsroom (2013) reported that
over 20 billion dollars are spent annually on providing care to those with antibiotic resistance
and 35 billion dollars per year are lost related to loss of productivity, when one cannot work due
to illness. There are five core elements recommended to combat the antibiotic resistance and
overuse problem which include preventing infections, preventing the spread of resistance,
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tracking resistance patterns, improving use of antibiotics (antibiotic stewardship), and developing
new antibiotics and diagnostic tests (CDC Newsroom, 2013). Michaelidis et al. (2016) described
hidden societal costs related to antibiotic resistance (SCAR) related to ambulatory antibiotic
prescriptions in the United States. The hidden SCAR per antibiotic prescribed in the United
States averaged to be $13.00 which, when calculating across four different methods, equated to
an increase of 65% per ambulatory prescription ordered (Michaelidis et al., 2016). Knowing the
cost of antibiotic resistance is difficult, but when comparing loss of work due to antibiotic
resistance to other comparable health issues, the cost is conservatively from $35,000 - $55,000
and may be more (Smith & Coast, 2013). Additional research is needed on the cost related to
antimicrobial resistance (Smith & Coast, 2013).
The use and misuse of antibiotics are major contributors to the development of antibioticresistant bacteria. A significant proportion of antibiotics used in LTCFs is inappropriate by drug
selection or altogether unnecessary and places residents at risk for developing antibiotic-resistant
infections (Hyuan, 2016). Antibiotic misuse (overordering, overusing, inappropriate use) leads to
resistance and C-diff (Mayo Clinic, 2012). Trivedi and Schooneveld (2012) identified that 3.2
million people currently reside in nursing homes in the United States and it is expected that this
number will double by 2050. One long-term care study has shown that antibiotics are over
ordered and 35% of antibiotics ordered for wound/skin problems, 42% for lower respiratory
infections, and 72% of urinary tract infections were not clinically justifiable (Trivedi, et al,
2012). According to the CDC (2017), antibiotic stewardship requires national attention. The
CDC has identified a gap in practice and has developed multiple goals to address this issue. The
goals include to set national guidelines on antibiotic use and cut inappropriate prescribing in
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hospitals, physician offices, and other healthcare environments (citation). In addition, the CDC
included the initiative which CMS (2015) has adopted for implementation of ASPs which is
mandated in LTCFs (US Department of Health, 2017). This project will advance nursing practice
by helping to reduce antibiotic overuse and costs associated with care for those with antibiotic
resistance. This project will hopefully help reduce resistance in this LTCF setting and C-diff
occurrences. Stone (2013) posited the consequence of antibiotic misuse in nursing homes as
extremely high and reducing the misuse leads to less resistance and adverse effects.
Implementing an ASP is one way to reduce misuse (Stone, 2013). The CDC (2017) shared the
annual savings related to ASP implementation at hospitals or other healthcare facilities was
$200,000-$400,000. Add summary and synthesis to fully conclude the section.
Local Background and Context
Texas is identified as prescribing antibiotics at the rate of 927/1000 population, which is
higher than many other states in prescribing antibiotics outside of the hospital setting (Hicks,
2017). When examining antibiotic usage in the LTCF setting, it has been identified by the
Houston Antimicrobial Symposium (Rios, 2017) that citywide antimicrobial stewardship
programs may help to overcome some of the barriers. In LTCFs, over the course of a year, up to
70% of nursing home residents get an antibiotic (CDC, 2017). In nursing homes, high rates of
antibiotics are prescribed to prevent urinary tract infections (UTI) and respiratory tract infections
(RTI). Prescribing antibiotics before there is an infection often contributes to misuse (CDC,
2017).
The practice setting for this scholarly project was a 62-bed long-term care skilled nursing
facility located in South Houston, Texas. In addition to the long-term care skilled nursing facility
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there is an independent living (IL) facility and an assisted living facility (ALF). The federal
government is requiring all LTCFs to implement ASP's (Stone, 2013). Under the Centers for
Medicare and Medicaid, rule F881, ASP's must be in place by November 2017 (Dall, 2016). The
facility had no ASP prior to July 1, 2017 and recently developed and implemented its antibiotic
stewardship program in July 2017. The facility had an average census of 36 residents from July
1, 2016 to July 1, 2017 with 8.75 new antibiotic starts per month. Twenty-two percent of the
population had antibiotics started each month and not all residents had a culture to substantiate
the antibiotic. my role within this project was to lead and analyze the data collected by the
practicum site and evaluate the outcomes based on the data provided. I had worked with this site
during the clinical practicum for the doctoral program developing and implementing an
evidence-based project which was the development and implementation of an ASP. The
proposed time for the stewardship program was over a 10-month period from July 2017 through
May of 2018. The data collection was conducted daily by the facility nurses each time a new
antibiotic was ordered. The data collected by the facility included capturing new starts, resistant
organisms, and those who were diagnosed with C-diff. This ongoing data collection was used for
the doctoral project. The facility staff was educated on data collection and the ASP program
during the evidence-based project development phase and will be re-educated as needed. In
addition to data collection on monthly flow logs, chart audits were conducted on each client with
a new antibiotic start to ensure all components of the ASP were being followed. The Quality
Assurance department captured the data in a summary format and presented it to management on
a quarterly basis. The number of new antibiotic starts, cases of resistance, and number of C-diff
infections prior to the ASP were compared to post ASP. If the occurrence of the C-diff infections
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is less than two resident occurrences in the proposed time, this was defined as rare and if this
occurred then the number of days between diagnosis of C-diff occurrences were counted.
Role of the DNP student
The role of the DNP student was to lead the doctoral scholarly project in collaboration
with the site, review the data collected, evaluate the data, communicate with the ASP team,
synthesize the outcomes, and develop an outcome report. The doctoral student functioned as the
interim leader for the project and provided guidance and a quality review of the data collected
and aggregated to ensure the program was being implemented and sustained as designed and in
accordance with the federal regulations. The doctoral student evaluated the data outcomes to
determine if the implementation of the ASP in this LTCF reduced the number of new starts,
resistance, and C-diff cases. The motivation in choosing this project was the desire to positively
affect outcomes in the geriatric population related to antibiotic overuse. The elderly population is
one that is vulnerable to antibiotic overuse and needs assistance in this area due to their health
and frailty. This student had a bias which is that not all staff may want to do their best in
focusing on implementing and sustaining the ASP. To overcome this bias, the doctoral student
recognized the bias and to overcome the bias, maintained an open mind when working with the
staff and maintained objectivity throughout the project by being open-minded. Friedman (2017)
shared being open and aware of one's own bias will help to deepen relationships and remove
barriers. The doctoral student employed the American Association of Colleges of Nursing
(AACN, 2007) eight fundamental essentials demonstrating the doctoral student competencies in
all eight areas. The table 3.0 on the next page outlines the project as it related to the AACN
fundamental essentials:
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Table 3
AACN Essential Competencies of a DNP student
DNP Essential

Tasks in the course project/DNP Essential

1.Scientific Underpinnings for Practice

DNP student to assess patterns of human
behavior related to their environment (elder
persons, their environment, antibiotic use and
resistance) and develop and apply nursing
actions or processes to affect antibiotic misuse
and provide positive change in health status
Target population- geriatric;
DNP student to propose strategies for
improvement in practice related to antibiotic
use
Literature search, best practices, design, direct,
evaluate a quality improvement related to
antibiotic stewardship program in a LTCF
DNP student to use web-based learning for
staff needs assessment and design evaluation
for this quality improvement activity
DNP student assumes leadership role for this
quality improvement activity advocating for
improvement in antibiotic stewardship in this
LTCF
DNP student will lead and employ effective
communication among the team at this LTCF
for this quality improvement project
DNP student will collect and analyze data for
the geriatric population relating to antibiotic
misuse and apply strategies for improvement
A comprehensive and systematic assessment of
the geriatric population in a LTCF for
antibiotic stewardship programming will be
conducted and evaluated by the DNP student

2.Organizational and Systems Leadership for
Quality Improvement and Systems Thinking

3.Clinical Scholarship and Analytical Methods
for Evidence-Based Practice
4.Information Systems/Technology and Patient
Care Technology for the improvement and
Transformation of Health Care
5. Health Care Policy for Advocacy I Health
Care
6. Inter-professional Collaboration for
Improving Patient and Population Health
Outcomes
7. Clinical Prevention and Population Health
for Improving the Nation’s Health
8. Advance Nursing Practice

(ACCN, 2006)
Role of the Project Team
The role of the ASP project team assembled for this project was multi-faceted. The ASP
project team was used to evaluate ongoing goal achievement, review reports prepared and

18
submitted by the QA nurse; work with the team in identifying areas needing improvement,
remediation, re-education of the staff, and established plans to implement the next phase of the
ASP as mandated by federal law which is the Infection Preventionist infection control position
by November 28, 2019 (Tritz, 2016). The Infection Preventionist is an individual who is highly
qualified in infection control and either has a bachelor's degree in epidemiology, microbiology,
medical technology, public health, or other healthcare science or is a healthcare professional with
specialized training in infection prevention and control beyond their initial professional degree as
outlined in federal regulation for LTCF 483.80 (CMS, 2017). Ongoing specialty training in
infection prevention and control through accredited continuing education and a nationally
certification in Infection Prevention and Control by NADONA (IP-BC Credential) or completion
of certification (CIC) Certification in Infection Control, or Certification Board of Infection
Control (CBIC) within 12 months of employment may also be required (CMS, 2017).
The process by which the team was presented with background information, evidence,
and other forms of information was two-fold, by email and face-to-face meetings. The team
members were expected to have shared their expertise with the internal/external organizational
operating systems within the facility, knowledge of the residents and rules and regulations, and
provided feedback within a timely manner to the members of the team. The team members did
not provide evidence for the project. Timely team communication was defined as within two
business days. Sandau and Dedrick (2012) shared evidence-based projects are a life-long process
and one should continue to research and find the most recent evidence to continually evaluate the
project and move forward. As the practicum site began this long journey of sustaining the ASP
one ASP leader the QA nurse, was assigned to continue to evaluate, research, and make changes
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based on the most current research. In December 2017 the facility QA Nurse retired after 25
years of service and the DON assumed the QA Nurse position. The DON had been on the ASP
team and has the knowledge for the program but changed roles within the team. This has
benefited the facility in that their QA department gained a previous ASP team member with
familiarity and leadership within the program previously. The LTCF has an antibiotic
stewardship team who will continue working, evaluating, and identifying the outcomes of the
program and reviewing its effectiveness and sustainability over time, beyond this project. The
ASP team members have defined roles in the program which are outlined in Table 4.
Table 4
ASP team member roles
DON

Administrator

Co-champion and infection control lead.
Lead / Supervise trainings.
Ensure monitoring of the interventions.
Monitor staff training.
Review whether materials are used
Develop findings with Performance Improvement Plan
(PIP) related to monitoring the new intervention.
Champion

Medical Director

Champion

Doctoral Student

Evaluate program implementation, effectiveness, data
collection, trends, barriers, challenges, sustainability,
outcomes
Monitoring staff: Collect/analyze/aggregate data monthly
to evaluate program effectiveness and sustainability

Quality Assurance Nurse
Assistant Director of
Nurses

Stewardship staff: Assist with ongoing program education
to nurses and ongoing implementation of program

Minimum Data Set Nurse
(MDS)

Stewardship staff: Assist with ongoing program education
to nurses and ongoing implementation of program
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Consulting Pharmacist

Co-champion, Antibiotic stewardship trained and
infectious disease knowledgeable, reviews antibiotics
monthly for the facility residents who are ordered
antibiotics

Lab

Co-champion
Antibiotic stewardship bio gram and meet with
stakeholders on cost and reports monthly
Summary
This section focused on the CDC/IHI and Johns Hopkins model for ASPs, the relevance

of antibiotic misuse and overuse in the geriatric population, the relevance to nursing practice, and
discussed antibiotic stewardship issues and efforts in Houston, Texas. In addition, the role of the
DNP student and ASP project team were discussed in detail. Next, the problem of antibiotic
overuse in Houston, Texas, the project plan for addressing this issue, an introduction to the
sources of evidence, operational data, and an analysis and synthesis of the data to be collected
will be discussed.
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Section 3: Collection and Analysis of Evidence
Introduction
The use and misuse of antibiotics are major contributors to the development of antibioticresistant bacteria. A significant proportion of antibiotics used in LTCFs is inappropriate by drug
selection (or choice), or altogether unnecessary, and places residents at risk for developing
antibiotic-resistant infections (Hyuan, 2016). Houston, Texas has developed an Antibiotic
Stewardship Community Symposium to address the issues of antibiotic misuse and overuse
(Rios, 2017). In this section, I will further explore and explain the problem, gap-in-practice, and
project purpose. The sources of evidence relied upon to address the practice-focused question
and collection of data with analysis are presented and approved. I will also summarize the
databases and search engines used for the project and discuss the organization’s operational data
used for the project. This section will also include analysis and synthesis of the participants, data
collected, and evaluation methods.
Practice-Focused Question
Over prescribing antibiotics in the Houston area is a problem. Rios (2017) noted that a
lack of appreciation for antibiotic resistance, knowledge, and a lack of resources are contributing
to the problem. Implementing city-wide ASPs can help to reduce barriers (Rios, 2017). The
purpose of this DNP project was to evaluate the effectiveness of reducing resistance, overuse,
and C-diff and to determine whether, in the geriatric population, the implementation of an ASP
reduces the overuse of antibiotics, C-diff, and resistance rates in the LTCF compared with no
ASP. The ASP was implemented in July 2017 and included policies, procedures, forms, staff and
practitioner education, online learning modules for newly hired nurses, data collection tools,
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monthly analysis of new antibiotics ordered, and development of an ASP team. The QA nurse
gathered the data collected and prepared the quarterly reports regarding the ASP program. The
CDC (2017) recommends various ways in which a nursing home can measure the ASP and its
outcomes. The outcome measures selected for this project included prevalence rate of resistance,
C-diff per 300 patient days (10 months), or days between C-diff associated disease if found rare
at the facility, and the number of new antibiotic starts before and after ASP implementation over
a 10-month period. Rare was defined for the scope and timeframe proposed for this project as
less than two positive resident resistant lab results per 300 resident days. The data collection
methods included the LTCF nursing staff documenting entries daily as applicable on monthly
logs on each unit in the LTCF of all residents with new antibiotic starts, cultures verifying
positive C-diff or resistance, chart audits on those residents who have antibiotics ordered,
laboratory antibiograms, and an analysis of the number of C-diff infections pre-ASP
implementation versus postimplementation.
Sources of Evidence
The sources of evidence relied upon for the practice-focused question Clostridium
difficile included searches using a variety of sources within the past 5 years (2012-2018). The
search strategies implemented included data searches to acquire the necessary scholarly literature
supportive of the project. The sources of evidence align with the purpose of the project, which
was to evaluate the effectiveness of an ASP in the LTCF setting relating to overuse, resistance,
and C-diff infections. The following is a list of sources of evidence used in this scholarly project:
•

Walden Library

•

Journal articles
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•

Governmental entities

•

Centers for Disease Control

•

Centers for Medicare and Medicaid Services

•

Searches using key words antibiotic stewardship, long-term care, CMS mega-rule,
antibiotic misuse, antibiotic cost, and antibiotic resistance

•

CINAHL

•

Medline

•

Cochrane Database of Systematic Reviews

•

Free Medical Journals

•

Walden Research Center

•

Agency for Healthcare Research and Quality

•

Institute for Healthcare Improvement

•

Google searches for antibiotic stewardship programs in long-term care facilities

•

State Operations Manual

•

World Health Organization

•

Houston Antibiotic Stewardship Symposium

The data were collected by the LTCF QA nurse using the following tools: (a) a unit
tracking log for nurses to document all new antibiotic starts, (b) a QA chart audit tool to evaluate
whether antibiotics ordered have a diagnosis, lab result on file, or diagnostic test with result
(prior to antibiotic being ordered), and duration for the antibiotic, as required by the ASP, (c) a
monthly summary tool to capture and track new antibiotic start data on a spreadsheet, and (d) a
QA quarterly report inclusive of new antibiotic starts to display outcome data quarterly.
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The CDC (2017) indicated that tracking infections, conducting surveillance, auditing
records, reviewing lab results, evaluating the antibiotic orders. In addition, documentation, use,
and duration are all important elements in evaluating the ASP (U.S. Department of Health,
2015). Tracking the number of antibiotic starts, cases of C-diff, and resistance are approved
methods for evaluating the impacts of the ASP (U.S. Department of Health, 2015) and are being
employed for this quality improvement project.
Collecting data relating to the number of new antibiotic starts, cases of C-diff, and
resistance before and after ASP implementation by the facility staff allowed for an evaluation of
the effectiveness of the ASP program on resistance, overuse, and C-diff within this LTCF
(Ibrahim & Polk, 2014). The staff had been collecting the number of new antibiotic starts, cases
of C-diff, and resistance prior to the implementation of the ASP in July 2017 and continue to
collect this data daily (C. Klapennebach, personal communication, November 8, 2017). Ibrahim
and Polk (2014) explained that "measurement of antimicrobial use before and after an
intervention and the associated outcomes are key activities of antimicrobial stewardship
programs" (p. 1). Testing data before implementation of an ASP and after implementation is a
recommended method called the nonexperimental design pre-and post-ASP design (Ibrahim, et
al., 2014). This collection method provided appropriate outcome data to evaluate the outcome of
the project, which was to evaluate the effectiveness of an ASP in a LTCF on C-diff, resistance,
and overuse/misuse of antibiotics.
The data collection methods included the LTCF nursing staff documenting entries daily
as applicable on monthly logs on each unit in the LTCF of all residents with new antibiotic starts,
cultures verifying positive pathogens, C-diff or resistance, chart audits on those residents who
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had antibiotics ordered, laboratory antibiograms, and an analysis of the number of C-diff
infections pre-ASP implementation versus postimplementation. The data was collected by the
LTCF QA nurse for evaluation and analysis: Unit tracking log for nurses to document all new
antibiotic starts; a QA chart audit tool to evaluate if antibiotics ordered had a diagnosis; lab result
on file or diagnostic test with result (prior to antibiotic being ordered); and duration for the
antibiotic, as required by the ASP; a monthly summary tool to capture and track new antibiotic
start data on a spreadsheet; and a QA quarterly report inclusive of new antibiotic starts to display
outcome data quarterly.
The data was verified by the QA nurse while conducting reviews of the medical records,
culture reports, Best lab monthly reports, and Relias documentation by the nursing staff. In
addition, the unit manager verified the accuracy of the monthly log before it went to the QA
nurse by reviewing the lab reports and orders and comparing the information to the log. The unit
manager and QA nurse were responsible for ensuring that information was not missing and was
correct by the reviews they were conducting.
Analysis and Synthesis
The systems used for recording, tracking, and organizing the evidence in this DNP ASP
evaluation project included the following: Best lab monthly reports on the number of antibiotics
ordered, an annual bio gram provided by Best lab, monthly infection control antibiotic unit logs,
laboratory culture reports, resident medical records, and the Relias software system (Relias,
2018) used by the nurses and QA department. The lab was using its own software system that
tracks each patient who has an antibiotic ordered, culture results, or cost related to antibiotic
usage, and provided the facility with monthly reports with this coded data (C. Klappenbach,
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personal communication, December 5, 2017). In addition, the facility, effective March 15, 2018,
was using the Relias software to input antibiotic orders, track lab and culture orders, and print
reports from this system monthly (K. Weathers, personal communication, February 27, 2018).
The Relias system provides electronic data, unlike the manual logs the facility was keeping. The
number of new antibiotic starts, number of C-diff cases, and number of resistant cases were
counted for each month before ASP implementation and compared to the number of cases after
ASP implementation to evaluate or determine the effect the ASP had on antibiotic overuse, cases
of C-diff, and cases of resistance at this LTCF. I coded the data, some preset codes and some that
evolved or emerged during data analysis. Outliers such as unnecessary therapy, prolonged
durations, and unusual resistance patterns were evaluated by the QA nurse (Ibrahim, et al.,
2014). Patient information was de-identified and summarized in the QA reports by the ADON
which I used to evaluate and analyze the data to compare the number of new antibiotic starts, Cdiff cases, and resistant cases before and after ASP implementation. I shared the data outcomes
with the stakeholders via a formal presentation at the end of the project.
Summary
The practice problem of antibiotic overuse and misuse is an issue nationwide (Hyuan,
2016). In the Houston area, an antibiotic stewardship symposium group has been assembled to
help combat this problem on a local level, and nursing homes have been mandated to implement
ASPs. In this section, I identified many sources of evidence to support this practice problem and
explained that data has been collected ongoing at the LTCF pre-ASP implementation (July 2017)
and is ongoing. The number of new antibiotic starts, cases of C-diff, and resistance were
captured monthly and were analyzed pre-ASP versus post-ASP over a 300-day period. The next
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section will expand upon the findings, implications, and recommendations relating to the effect
the ASP had on this facility. The project team's role, strengths and limitations of the project, and
dissemination of this work will be presented and discussed. Finally, an analysis of self will be
shared relating the dnp student to the different roles assumed throughout the project and in
relation to the scholarly journey.
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Section 4: Finding and Recommendations
Introduction
Antibiotic over use and inappropriate use continues to be problematic in the LTCF
environment. There are four core elements to reducing resistance which include preventing
infections, tracking resistance patterns, improving antibiotic use (stewardship), and developing
new antibiotics and tests (U.S. Department Disease Control, 2013). The practice focused
question is: In the geriatric population does the implementation of an ASP reduce the overuse of
antibiotics and affect resistance and C-diff rates in the LTCF compared with no ASP? The
purpose of the doctoral project was to evaluate the affect an ASP had on antibiotic use, overuse,
cases of resistance, and C-diff.
The sources of evidence for this project covered the period from September 2016 through
May 15, 2018 (10 months prior to ASP implementation to 10 months post-ASP implementation).
Sources of evidence included the monthly antibiotic unit logs, physician orders for antibiotics,
results of cultures obtained, type of infection documented on the logs and reports, monthly
facility lab reports from Best care lab, facility census, and the quality assurance reports
summarizing the number of new antibiotic starts monthly. The staff at the LTCF documented the
information collected, provided the de-identified monthly antibiotic logs and lab reports for
analysis, and assisted when questions arose, or verification of data was required. The monthly
lab reports were compared against the unit monthly antibiotic logs to ensure that the correct
number of resistances were recorded, the correct number of new antibiotic starts were recorded
based on the number of positive culture results, and clarification was obtained for any
discrepancies by asking the ADON. All infections that were present upon admission were
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denoted on the monthly log and were not counted. Those patients who had re-treatments for
existing infections were counted one time. The number and types of infections were reviewed to
ensure duplication did not occur if a resident had an ongoing infection from one month to the
next. If a resident was diagnosed and treated with a new infection from a different source, this
was counted. For example, if a resident had an upper respiratory tract infection in January and
then developed a urinary tract infection in February and was treated with different antibiotics,
these were counted as two different new start orders. The resident information was de-identified
on the logs so to eliminate possible duplication of entries the resident room numbers were
tracked on the monthly logs as a part of the analysis process.
Findings and Implications
Upon reviewing, analyzing, and evaluating the data collected it was identified that the
census for the facility remained fairly stable and the average daily census was 39 residents prior
to ASP implementation and 37 after the ASP was implemented. When reviewing the effect the
ASP had within the facility during this time period it was identified that antibiotic ordering
declined. The facility ensured that it had culture reports consistently with results when ordering
antibiotics. The facility reported that they did continue to use the orientation training modules for
newly hired nurses for the stewardship program 100% of the time. The total number of cases of
resistance over the time period evaluated declined from 12 cases prior to the ASP being
implemented to 10 cases after the ASP was implemented. This equated to a 16.67% decline. The
number of monthly new antibiotic orders for the time period evaluated declined from 120 to 110
respectively which was an 8.3% change. For this population, these numbers are statistically
significant for the sample size used. The number of cases of C-diff remained unchanged. There
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were zero cases of C-diff prior to the ASP implementation and zero cases afterwards. Table 5
outlines the findings.
Table 5
ASP Outcome Indicators
Pre ASP
9/1/16-7/15/17

Post ASP
7/16/17-5/15/18

Average monthly census

39

37

# New antibiotic starts orders

120

110

11.43

10.48

#MRSA

5

3

#VRE

4

1

#ESBL*

3

6

#C-diff

0

0

Average monthly new antibiotic orders

*new tracking by facility during the project

One of the limitations of the project was that the history of antibiotic use and resistance
was not always known for each of the residents. In addition, the accuracy of the monthly logs did
not always match up 100% of the time with the lab reports requiring reverification. The time
period since implementation of the ASP was less than 1 year, the months compared were not
duplicative (i.e. January-December, one year) which made it more difficult to visually see the
results comparatively. The sample size was small ranging between 37-39 residents and was
limited to one facility. It was identified during the project that the Bestcare lab contract was not
in effect until January 1, 2018, so data collection was done manually for September-December
2016. Finally, the duration of antibiotic use was not evaluated in this project.
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Antibiotics are a limited resource and need to be used sparingly (U.S. Centers for Disease
Control, 2013). The benefits of implementing an ASP at this LCTF showed a positive impact on
the number of new antibiotics ordered, assisted in reducing the number of resistance cases, and
ensured antibiotics were ordered as needed and verified by culture results. Not only do these
outcomes positively impact this geriatric population but the community as well. Many of the
nurses who work at this LTCF work part-time elsewhere, belong to local groups and
associations, and have reported that they have shared their ASP program and what they have
learned regarding becoming stewards of antibiotics with others outside of the facility. The
findings from this project will be shared with the Houston Antibiotic Stewardship committee and
will be presented in December 2018 in Las Vegas at the American Nursing Symposium
conference in the hope of promoting positive social change on a state and national level.
Recommendations
As the facility’s staff continues to be stewards of antibiotic use, there are several
recommendations to implement so that the facility continues to improve and maintain its ASP
program. The following are recommended solutions for not over ordering, overusing, or
inappropriate use of antibiotics for the elderly population in this LTCF:
• Conduct chart audits on those residents with infections and use the audit tool in
the ASP program developed and provided in Appendix B.
• Implement and use the monthly quality assurance summary form in Appendix C.
• Ensure all new hires are oriented to the ASP program and comply with the facility
policies.
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• Conduct biannual education with the staff to maintain awareness and discuss
statistics ongoing.
• Continue to track number of new antibiotics ordered monthly and resistance cases
monthly.
• Implement the federally mandated Infection Preventionist job position, which is
required this November 2018.
• Customize the transfer form in Point Click Care to include antibiotic history of
resident when transferring them out (when they were last on antibiotics or history
of resistance) or use the form provided in Appendix C.
• Consider extending the project to December 2018 to have comparative data.
• Capture duration of antibiotic use as outlined in the QA policies.
Contribution of the Doctoral Project Team
The doctoral project team included the preceptor, administrator, quality assurance nurse,
DON, ADON, and the laboratory representative. Each person on the team provided guidance and
assistance as outlined in Table 4. The team members who provided the most support were the
ADON and administrator. The DON and QA nurse delegated their responsibilities to the ADON
and the medical director relied on the facility staff to work with me. The ADON provided the
unit monthly logs, answered questions, verified data, and worked with the unit manager to ensure
the data captured was complete, accurate, and de-identified prior to giving it to me. The
administrator assisted when the lab reports were needed and, when there were delays due to
changes in the LTCF nursing management, in getting the lab reports to the facility and assigning
a secretary to de-identify the 20 months of data for the project. My preceptor reviewed the initial
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findings, limitations, recommendations, and provided input on additional limitations to include in
the report. The project team reviewed the final report and findings and are responsible for
adoption of the final recommendations. It was mentioned by them director/preceptor that
duration was not captured at this point and the project has the potential to be extended to include
this data and to obtain a complete calendar year of data for comparison of July 2017 (pre-ASP)
to July 2018 (post-ASP).
Strength and Limitations of the Project
This project had many strengths and limitations. One strength was that the project team
was committed to the project and worked with me to implement the ASP. Another strength was
the outcome evaluation of the project demonstrated implementing an ASP does help to reduce
over ordering and overuse of antibiotics in this LTCF. The project also provided support for the
argument that many health care professionals are not aware how severe the overuse, misuse, and
inappropriate use of antibiotics is at their facility. When conducting orientation and training with
the staff many did not understand ASPs or the importance of their role in helping to reduce the
problem of over ordering, inappropriate use, or ensuring culture results were back prior to
antibiotic ordering. In a study conducted with a long-term acute care (LTAC) hospital where a
survey was completed by the staff relating to antibiotic stewardship it was found that most were
aware of the resistant bacteria but only 35% were confident in how to treat or reduce them
(Mushtaq, et al., 2018). Finding online training modules that could be loaded into the facility
Relias learning management system for ongoing training and orientation of new staff members
was another strength of the project. These modules will provide sustainability of knowledge for
new and existing employees. The facility complying with using the training modules for all
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newly hired nurses since inception of the ASP is another strength to increase knowledge and
sustainability of this issue and project.
There were several limitations of the project as mentioned previously. These are
summarized in Table 6.
Table 6
Limitations of the ASP Project
Limitation

Possible Solution

Antibiotic history not known for
questionnaire on history
the resident
coordinator to collect

Implement

Antibiotic resistance history not
questionnaire on history
known for the resident
coordinator to collect

Implement

for admission

for admission

Small Sample Size - 1 facility
include more
n = 37.5
Houston area

Increase sample size-

Duration of antibiotic use not measured

Collect duration data

Manual logs maintained with no lab back up
September 2016-December 2016

None available

facilities in the

It is recommended as a future project that this project be replicated and send an invitation
to all Houston LTCFs to participate in providing monthly data on new antibiotic starts, cases of
resistance, and C-diff with the goal of gaining 10% of the Houston area LTCFs to participate so
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that we can evaluate the effects of ASPs over the course of 1-year postimplementation in the
LTCFs of the Houston area.
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Section 5: Dissemination Plan
Introduction
In this section, I describe the plans to disseminate ASP project work to the institution
experiencing the problem in practice. The audiences and venues that would be appropriate for
dissemination of the project to the broader nursing profession will be clarified and an analysis of
self in my role as practitioner, scholar, and project manager drawing connections between this
project experience, present state, and long-term professional goals will be presented. I also
describe the completion of the project along with the challenges, solutions, and insights gained.
Plans for Dissemination
The results of the analyzed data were presented to the stakeholders and management team
via a formal written report. The report summarized the number of new antibiotic starts, cases of
C-diff, and resistance before versus after ASP implementation. In addition, findings regarding
the monthly logs, quarterly QA reports, audits conducted, compliance with the ASP policies and
procedures, and areas identified as needing improvement were incorporated into the report. Also
included in the report were recommendations for the future and a request to allow me to return at
the 24-month mark to evaluate the effectiveness over a 2-year period for publication. Audiences
and venues that would be appropriate for dissemination of the project include the National
Association of Directors of Nursing Association (NADONA), geriatric magazines, and Elsevier.
In addition, I accepted an invitation to be a keynote speaker in Las Vegas at the annual American
Nursing 2018 Symposium to sit on the scientific board and present this doctoral project. Another
plan for dissemination includes working with the Houston Antibiotic Stewardship Committee to
incorporate LTCFs so that they are represented and have an active role within the committee
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because, currently, the city of Houston focuses on the hospitals and LTCFs have no
representation.
Analysis of Self
One thing that I have learned about myself that I did not know prior to this project is that
I truly enjoy quality improvement and evidence-based practice. During this DNP project journey,
I have assumed the role of scholar by researching current evidence and applying it to the systems
and processes relative to antibiotic stewardship programming at this LTCF. I have assumed the
role of project manager, leader, and practitioner. Through my work with the staff, many staff
members have developed a better understanding of antibiotic stewardship and are practicing not
overusing or misusing antibiotics. I feel I personally have made a huge impact on the facility
staff, and their practices have improved based upon this doctoral project and focus on ASPs in
this LTCF. participating in these types of activities in the future. This project has motivated me
to want to become involved in our local ASP Houston Committee and team and has promoted
my confidence to approach the Houston ASP Committee with my ideas of incorporating LTCFs
into their programs and goals for our city.
As a practitioner, I have grown tremendously during this project both professionally and
personally. The specific areas I have grown in include integrating current science and evidence
within an LTCF to benefit its residents, learning how to adapt to an ever-changing team of
individuals throughout the length of the project, learning how to engage new and different team
members throughout the project, gaining self-confidence as the leader of the project, overcoming
my insecurities and working with a group that was initially strangers, researching and identifying
the proper framework and tying it to the practice of antibiotic stewardship, learning how to
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prepare a formal presentation, and disseminating the information to the stakeholders. Another
area that was a personal challenge for me was working in an area that was neither quiet nor
private, and therefore not conducive to effective critical thinking. I initially worked in a private
office with the first QA nurse, but when the staff changed, the new administrator moved my
work area to the front desk of the facility. I did request initially another place to work and
suggested an alternative solution that was not an office, but I was told that the front desk was
where I was to work. This work space posed many obstacles for me, such as visitors immediately
coming to me all day thinking I worked for the facility, staff members asking me questions that I
could not answer as I do not work at the facility, and residents coming up to me at the desk all
day wanting help or to visit. The environment was very loud and full of distractions, such as call
lights going off for extended periods, door alarms sounding, wheel chair alarms going off, staff
hustling about me, and meetings taking place near my work area, sometimes with the door open.
I am a person who generally requires a quiet place to work, so this was a huge challenge for me.
I overcame these obstacles and learned to block out the sounds and focus on the work for the
project. Another challenge was protecting the privacy of the documents I was working with and
my laptop which I brought with me. Also, I was not allowed to eat at the front desk, so I had to
secure my work if I wanted to take a break or get a staff member to keep an eye on it for me. I
learned to adjust to the work space provided and work with the team so that there was no
negativity with the project. I laugh when I picture myself on my knees crawling under the desk to
plug my laptop in, which was not an easy task to do!
Another area of growth for me was balancing the relationship between the newly
appointed administrator, the staff, and myself as the project lead. I was expected to lead the
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project but was limited in my authority to do so. The administrator who replaced the one who
was terminated in December 2017 made it very clear that if I needed anything for the project I
was to go through her, exclusively. This basically eliminated my ability to work with the team.
She shared with me that “we don't like chatty people.” I recall one time I asked the physical
therapy (P.T.) director if they had gotten a set of policies and procedures in their office yet for
ASP and was informed later in the same day by the administrator that she “heard I had talked
with the P.T. director” and that if I have any questions I must go through her. I learned that I
needed to tap into all my practitioner team leading skills to work with the administrator and staff
to make this project work. I discussed ideas and the project with the staff to gain insight, and
then I went to the administrator with what was discussed. This way, I was still going through the
administrator for decision making but through these interactions I was able to build a team with
the staff whom I needed to support the project. Another strategy I used to overcome this
restriction was, when I did informal education with the staff, I used it as a chance to build our
relationship further, connect on a personal level, have side-bar discussions regarding the ASP
goals, and gain their support. I brought the staff donuts and cookies, provided positive verbal
reinforcement, and remained positive throughout the process. This worked well, and as I
concluded the project, the staff were friendly and supportive, and even the administrator warmed
up to me. In conclusion, I feel as a practitioner now, I am ready, able, and willing to conduct
further projects/studies in the nursing profession and am motivated to continuing research and
improving practice.
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Completion of Project
The completion of this doctoral project had its challenges. One challenge encountered
was the lack of support by the nursing department in providing the collected data in a timely
manner, and the administrator had to assist me in getting the data from the lab for the 20-month
period enveloped within the project. In addition, the new DON had shown little to no interest in
the project and was difficult to develop a working relationship with as she had just started in
December and was overwhelmed with her new duties and in learning her new position within
this LTCF. Her availability was limited, and her interest was waning. One way to overcome this
challenge was to approach her when she acknowledged she had time to talk and to share what
was needed for the project. Her response with this approach was positive and more welcoming.
Another solution was to work with the ADON and try and get her to assist, which she did,
providing the monthly de-identified unit logs even though she was not timely in getting these to
me, and it took several requests over several weeks to get the information. The QA nurse did not
conduct the chart audits as the policies and procedures required for January to May 2018;
however, the monthly lab reports compared to the monthly unit logs and the documentation on
the log did provide the required data regarding whether a culture was ordered, what the results
were, and whether the antibiotic was ordered per policy and procedure. I was assigned to contact
the lab directly to get the required monthly reports printed out; however, due to my relationship
with the facility, the administrator had to establish the generation of the reports for this study and
the reports needed to be de-identified for me. The administrator was frustrated that neither the
DON or QA nurse had established online accounts with the lab and the administrator had to step
in and assist me in getting the monthly lab reports. I learned that sometimes even diligence,
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patience, and using all the skills in one’s tool box to lead a project may not be enough and key
management may need to get involved if the nursing leadership does not respond.
Summary
In summary, conducting this doctoral project has provided me the opportunity to evolve,
learn, practice, and become competent in the essential competencies of the DNP program. This
has been a roller coaster experience and has been challenging at times. It has provided me with
the opportunity to grow and become ready to conduct research in nursing practice after
graduation.
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Appendix A: Institutional Review Board Approval

Your IRB approval number is 04-04-18-0293257.
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Appendix B: Chart Audit Tool

New Antibiotic Starts- Phase One
Effective July 10, 2017
Instructions: Please complete this audit tool on the patient record to evaluate the antibiotic stewardship
program. This tool is to be done weekly on all patients who received antibiotics by the Unit Manager. The
completed tool is forwarded to the QA Nurse for incorporation into the quality assurance program.
Week of: ______________________ (Week of: i.e. Monday- Sunday 6/26/17- 6/30/17)Jan  Feb

 March April  May  June  July  Aug  Sept  Oct  Nov  Dec
Resident
Name

Date
Antibiotic
Ordered

Diagnosis for
Antibiotic on
the chart

Duration of
Antibiotic

Ex. Joseph
Silak

07/10/17

UTI

14 days

1
2.
3.
4.
5.
6.
7.
8.
9.
10.

Diagnostic procedure
(lab, x-ray, culture)
on file showing what
pathogen?
U/A 7/10/17

Results of lab, x-ray,
pathogen growing?
Pending – atb started
without result
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Appendix C: New Antibiotic Starts- Phase One Monthly Results
Data Collected by: ______________________________________________________
First Name
Last Name
Title
Date
Monthly Totals: _______________
Jan  Feb  March April  May  June  July  Aug  Sept  Oct  Nov  Dec
Threshold for Compliance: 80%

# New Antibiotic

#Residents who

# Residents with

#Residents with

# results back

Orders

had Duration

diagnosis to

tests ordered to

prior to ordering

documented in

support antibiotic establish

the orders # days

order

diagnosis for atb

7/8

7/8

6/8

5/8

87.5%

87.5%

75%

62.5%

atb

for antibiotic
i.e. 8
Month Results:

% compliance
i.e.
Month %:

Calculation for % of compliance=
# Residents with duration documented divided by total # new antibiotic starts x 100 = %
# Residents with diagnosis to support atb order divided by total # new atb order starts x 100 = %
# Residents with tests ordered to establish dx divided by total # new atb order starts x 100 = %
# Results back prior to ordering atb divided by total # new atb order starts x 100 = %
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Appendix D: Inter-facility Infection Control Transfer Form

